Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Graham Corporation (GHM)

$85.07
+0.88 (1.05%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Defense-Driven Transformation: Graham Corporation's Margin Inflection Meets Naval Supercycle (NYSE:GHM)

Executive Summary / Key Takeaways

  • A Turnaround Executed to Perfection: Graham Corporation has completed a remarkable transformation from negative EBITDA margins (-3.4% in FY2022) to a 10.7% adjusted EBITDA margin in FY2025, driven by a strategic pivot from 75% commercial/25% defense to a 40%/60% mix that leverages sole-source positions on critical U.S. Navy programs.

  • Concentration as Double-Edged Sword: Defense now represents 85% of the record $515.6 million backlog, providing multi-year revenue visibility through the mid-2030s but creating vulnerability to defense budget shifts, program cancellations, or procurement delays that could impact the top line.

  • Margin Inflection with Scalability Evidence: The 30.6% year-over-year defense segment growth in Q3 FY2026, combined with 200 basis points of SG&A leverage (18.6% of sales vs 20.6% prior year), demonstrates that fixed cost absorption is working, supporting management's path to low-mid teen EBITDA margins by FY2027.

  • Valuation Demands Flawless Execution: Trading at 62.9x earnings and 39.1x EV/EBITDA, the market has priced in not just the turnaround success but also execution of the "improve" and "growth" phases, leaving little margin for error on defense spending, acquisition integration, or capacity ramp.

  • The Critical Variable: The investment thesis hinges on whether Graham can diversify its defense concentration through successful commercialization of new energy (SMRs, hydrogen) and space opportunities while maintaining its sole-source moat on Virginia-class submarines and torpedo programs.

Setting the Scene: From Commercial Chaos to Defense Dominance

Graham Corporation, founded in 1936 and headquartered in Batavia, New York, spent decades as a respected but cyclical supplier of fluid, power, heat transfer, and vacuum technologies to commercial energy and process markets. The company's business model traditionally relied on large capital projects in oil refining, petrochemicals, and alternative energy—markets known for cycles driven by commodity prices, geopolitical uncertainty, and tariff impacts. This exposure created a fundamental instability that came to a head in fiscal 2022, when adjusted EBITDA margins reached negative 3.4% on $97.5 million in revenue.

That crisis forced a strategic reckoning. Management launched a five-year vision in FY2022, beginning with a "stabilize" phase focused on rebuilding the foundation across people, processes, and core operations. The results show revenue more than doubled to over $210 million by FY2025, while the portfolio mix inverted from 75% commercial to 60% defense. Backlog tripled to $412 million, and adjusted EBITDA margins recovered to 10.7%. This was a deliberate repositioning into mission-critical defense applications where Graham had built leading, often sole-source, positions over decades.

Loading interactive chart...

The company now sits at an inflection point. On June 10, 2025, leadership transitioned with Dan Thoren moving to Executive Chairman and Matt Malone becoming President and CEO, marking the official entry into the "improve" and "growth" phases. The question for investors is whether this transformation has created a durable, high-margin compounder or simply concentrated risk into a different flavor of cyclicality. The answer lies in understanding how Graham makes money today, what differentiates its technology, and whether the valuation premium reflects sustainable competitive advantage.

Technology, Products, and Strategic Differentiation: The Sole-Source Moat

Graham's core value proposition rests on engineering expertise in vacuum, heat transfer, and high-speed turbomachinery for environments where failure is not an option. In the defense segment, this translates into equipment for nuclear and non-nuclear propulsion, power, fluid transfer, and thermal management systems for U.S. Navy submarines and aircraft carriers. The company has built what it describes as "in most instances a sole source position" for certain systems, a status that eliminates price competition and creates decade-long revenue visibility.

The significance lies in the fact that sole-source positioning on programs like the Virginia-class submarine and MK48 Mod 7 heavyweight torpedo transforms Graham from a commodity component supplier into a strategic partner whose production capacity directly impacts national security. When the Navy accelerates ship build schedules due to geopolitical tensions, Graham's ability to meet those schedules becomes a competitive advantage that reinforces its incumbent position. The $136.5 million follow-on contract for Virginia-class submarines extends through the mid-2030s, while the $25.5 million torpedo order includes three additional option years. This is embedded infrastructure.

The recent acquisitions of Xdot Bearing Technologies and FlackTek Manufacturing deepen this moat in different ways. Xdot, acquired for $900 thousand in October 2025, brings patented foil bearing technology that delivers superior performance while reducing development and production costs for high-speed pumps and compressors. Management is already leveraging this technology for opportunities in small modular nuclear reactors and fuel cell blowers, expanding the addressable market beyond traditional defense applications. FlackTek, acquired for $35 million in January 2026, adds advanced materials processing as a third core technology platform, with its MEGA line representing the world's only production-scale bladeless dual asymmetric centrifugal mixer . This reduces mixing cycles from hours to minutes, creating a disruptive value proposition where the primary competitor is manual mixing.

These acquisitions align with Graham's M&A criteria: engineered product portfolios, process-critical applications, domestic customer bases, and opportunities for long-term organic growth. The integration is progressing, with Xdot already contributing $509 thousand to backlog and FlackTek adding approximately $30 million in annualized revenue with a 60% exposure to energy and process markets. This diversification within mission-critical applications reduces dependence on any single program while maintaining high-margin, sole-source characteristics.

Organic investments in capacity further strengthen the moat. The new 30,000 square foot Batavia manufacturing facility, completed in July 2025 with $13.5 million in customer grant support, incorporates automated welding and optimized product flow specifically for Navy programs. The $3.6 million advanced radiographic testing equipment, supported by a $2.2 million defense customer grant, can penetrate entire structures in 1-2 shots, simplifying inspection and rework. These are capability enhancements that make Graham more indispensable to its defense customers while improving unit economics through automation.

Financial Performance & Segment Dynamics: Evidence of Scalability

Graham's financial results provide evidence that the strategy is working and that the business model is scaling. For Q3 FY2026, revenue increased 21% to $56.7 million, driven by the timing of key project milestones in defense, contributions from new programs, and better pricing. Adjusted EBITDA rose 50% to $6 million, achieving a 10.7% margin that demonstrates both operating leverage and disciplined execution. For the first nine months of fiscal 2026, net sales increased 18% to $178.2 million, with defense sales up 21.3% and energy process sales up 18.7%.

Loading interactive chart...

The segment dynamics reveal why the defense pivot matters for margins and growth sustainability. Defense now represents 62% of quarterly sales and 85% of the $515.6 million backlog. This concentration creates a revenue base that is more predictable than the cyclical energy process market. The defense segment's 30.6% growth in Q3 FY2026 resulted from timing of project milestones, contributions from new programs, better pricing, and growth across existing platforms. This breadth suggests the growth is sustainable rather than a one-time step-up from a major award.

Energy process sales grew 13% in Q3, with demand in new energy markets (particularly small modular reactors) offsetting weaker aftermarket orders. Management estimates the NextGen steam ejector nozzle represents a market opportunity exceeding $50 million over the next 5-10 years. While traditional energy markets face headwinds from lower gas prices and geopolitical uncertainty, the SMR opportunity positions Graham at the forefront of clean energy transition. The company is in early development phases, supplying helium circulators and molten salt pumps for next-generation nuclear reactors. This provides a potential second growth engine that could reduce defense concentration over time, though commercial deployment remains slow.

The space segment, while smaller, serves a strategic purpose. Sales declined 18% in Q3 and 6% year-to-date, reflecting the inherent lumpiness of launch provider commercialization. However, Barber-Nichols booked $22 million in new orders from six industry-leading commercial space launch customers in Q2, and the new cryogenic propellant testing facility in Jupiter, Florida—completed in February 2026—has generated interest from customers wanting to test assets and validate Graham as a provider. The facility's power-on capability differentiates it from competitors and positions Graham to capture revenue as low-rate production programs scale up.

Margin expansion demonstrates the scalability of the operating model. Gross profit margin reached 23.8% in Q3; while this was a 100 basis point decline, it reflected a higher level of material receipts that typically carry lower margins, not structural deterioration. More importantly, SG&A expenses as a percentage of sales declined 200 basis points to 18.6%, showing leverage of fixed overhead as volumes increase. The effective tax rate dropped to 11% in Q3 due to higher R&D tax credits, providing a near-term earnings boost. For the full year, management expects gross margins of 24-25% and SG&A at 17.5-18.5% of sales.

Cash flow generation supports the growth strategy. Operating cash flow was $16.1 million for the first nine months of fiscal 2026, compared to $27.9 million in the prior year, reflecting working capital investments needed to support backlog growth. Net capital expenditures of $13.3 million represent 7.4% of sales, within management's target range of 7-10% annually. With no debt outstanding and $22.3 million in cash, plus an $80 million revolving credit facility, Graham has liquidity to fund organic growth and acquisitions. The pro forma leverage ratio after the FlackTek acquisition is approximately 1.2x, with only $20 million drawn on the facility.

Loading interactive chart...

Outlook, Management Guidance, and Execution Risk

Management's updated fiscal 2026 guidance reflects confidence in both organic momentum and acquisition contributions. Net sales are projected at $233-239 million, with adjusted EBITDA of $24-28 million. The guidance includes an estimated $1-1.5 million tariff impact. Management reiterated its long-term objective of achieving 8-10% average annualized organic revenue growth and low-mid teen adjusted EBITDA margins by fiscal 2027.

This guidance suggests the transformation is entering a new phase where growth investments should yield margin expansion. The company is tracking to plan through the first nine months, with a year-to-date book-to-bill ratio of 1.6x versus a long-term target of 1.1x. This indicates that demand remains robust and that backlog conversion should support revenue growth. Approximately 35-40% of the $515.6 million backlog is expected to convert to revenue within one year, with another 25-30% converting within two years.

Execution risks center on acquisition integration, capacity ramp, and operational efficiency. The Xdot integration is progressing, with technology already being leveraged for SMR and fuel cell opportunities. FlackTek, acquired in late January 2026, adds complexity with its $30 million revenue base and potential $25 million in earn-outs over four years. The Batavia ERP system implementation, expected online by year-end 2025, aims to improve transactional efficiency. The new Batavia facility and cryogenic test facility must ramp efficiently to avoid margin compression from underutilization.

Management's commentary on these risks is transparent. They acknowledge that the third quarter is historically the lowest revenue quarter due to seasonal patterns. They state that capital investments are crucial for achieving fiscal 2027 goals but that performance improvement will be gradual rather than a "step change." This suggests management is setting realistic expectations for the pace of margin expansion.

Risks and Asymmetries: Where the Thesis Can Break

The most material risk is defense concentration. With 85% of backlog tied to U.S. Navy programs, any shift in defense budgets, program cancellations, or procurement delays could impact revenue and earnings. The Virginia-class submarine program depends on continued congressional funding and geopolitical priorities. A single major program delay could push out revenue recognition and compress margins as fixed costs are spread over lower volumes. This concentration risk is the central vulnerability that could impact the investment thesis.

Valuation risk is also significant. At 62.9x earnings and 39.1x EV/EBITDA, Graham trades at a premium to industrial peers like Flowserve (FLS) (28.6x P/E, 14.5x EV/EBITDA) and Curtiss-Wright (CW) (54.4x P/E, 33.5x EV/EBITDA). The market has priced in turnaround success and execution of the growth phase. Any stumble—whether from defense budget pressure, acquisition integration issues, or margin compression—could trigger a multiple re-rating.

Space market volatility presents a different risk profile. While the segment represents only 6% of backlog, it is characterized by customers who may require additional funding to continue operations. The 18% Q3 sales decline demonstrates this variability. However, the asymmetry here is positive: the cryogenic test facility creates a capability that competitors lack, which could convert into revenue if the commercial space market stabilizes.

Geopolitical and supply chain risks are present. Tariffs have impacted results by approximately $1 million year-to-date, and management expects $1-1.5 million in full-year impact. Supply chain disruptions could affect the timing of large capital projects, particularly in the energy process segment where lower gas prices have pushed out order timing. The company's domestic manufacturing footprint and sole-source defense positions provide some insulation.

The whistleblower complaint at Graham India Private Limited, while resolved with remedial actions, highlights operational risk in international expansion. Management's transparency in reporting findings demonstrates governance strength, but future compliance issues could impact customer relationships.

Competitive Context: Niche Dominance vs. Scale Disadvantage

Graham's competitive positioning is defined by specialization versus scale. Against Flowserve, Graham is a fraction of the size but offers efficiency in vacuum and heat transfer applications for extreme environments. Flowserve's broad pump portfolio excels in general industrial fluid handling but lacks Graham's sole-source positions on mission-critical defense systems. This allows Graham to command premium pricing in its niche, though it limits total addressable market.

Chart Industries (GTLS) ($9.9B market cap) dominates cryogenics for LNG and hydrogen, overlapping with Graham's space and energy opportunities. Chart's scale provides advantages in clean energy infrastructure, but Graham's specialized turbomachinery for rocket systems offers faster integration and performance under vacuum extremes. The Florida cryogenic test facility positions Graham to compete, but Chart's established market presence represents formidable competition.

Curtiss-Wright is perhaps the most direct comparable, with similar defense exposure and engineered products for aerospace and naval applications. CW's $3.5B revenue and 20.3% operating margins demonstrate what scale can achieve. However, Graham's vacuum ejectors deliver efficiency in submarine systems compared to CW's broader avionics focus. The key difference is diversification: CW's defense concentration is offset by commercial power and industrial markets, while Graham remains more exposed to Navy program volatility. Financially, CW's 19.4% ROE and 8.2% ROA exceed Graham's 12.2% and 3.8%, reflecting asset efficiency that Graham must improve to justify its valuation.

Babcock & Wilcox (BW) ($1.95B market cap) focuses on energy technologies with similar heat transfer applications. BW's recent turnaround and data center project win demonstrate the opportunity in thermal management for AI infrastructure. Graham's vacuum condensers provide efficiency in petrochemical heat transfer, but BW's wins in data centers show where the market is heading. Graham's lower scale limits its ability to compete for the largest energy projects, though its defense focus provides stability.

Graham's competitive advantages center on proprietary technology, long-standing defense certifications, and aftermarket services. The sole-source positions create barriers that would take competitors years and significant capital to replicate. The aftermarket network generates high-margin recurring revenue. However, vulnerabilities include limited scale leading to higher operating costs per unit and technological gaps in commercial digital tools compared to larger peers.

Valuation Context: Premium Pricing for Premium Positioning

Trading at $84.93 per share, Graham Corporation commands valuation multiples that reflect its successful turnaround and defense market positioning. The TTM P/E ratio of 62.9x and EV/EBITDA of 39.1x represent significant premiums to industrial machinery peers. Flowserve trades at 28.6x earnings and 14.5x EV/EBITDA, while Curtiss-Wright trades at 54.4x earnings and 33.5x EV/EBITDA.

The price-to-sales ratio of 3.96x is above Flowserve (2.03x) and Chart Industries (2.32x). This suggests the market is paying for margin expansion potential rather than current profitability. The enterprise value of $924 million represents 3.89x revenue, reflecting expectations of sustained growth and margin improvement.

Balance sheet strength supports the valuation premium. With no debt outstanding, $22.3 million in cash, and an $80 million undrawn credit facility, Graham has the liquidity to fund growth. The pro forma leverage ratio of 1.2x after the FlackTek acquisition remains conservative. Return on assets of 3.8% and return on equity of 12.2% lag peers but reflect recent capacity investments. As these investments ramp, ROE should improve, justifying current multiples.

The valuation premium implies the market expects Graham to achieve its FY2027 targets of 8-10% organic growth and low-mid teen EBITDA margins while successfully integrating acquisitions and commercializing new energy opportunities. Any deviation from this path could trigger a multiple re-rating toward peer averages.

Conclusion: A Compelling but Concentrated Transformation

Graham Corporation has executed an impressive industrial turnaround, transforming from a cyclical commercial supplier into a mission-critical defense partner with sole-source positions, multi-year backlog visibility, and margin expansion potential. The defense pivot has created a durable moat that competitors cannot easily replicate, while recent acquisitions and capacity investments provide optionality in clean energy and space markets.

However, this success has concentrated risk. With 85% of backlog tied to U.S. Navy programs, the investment thesis is a bet on continued defense spending and shipbuilding schedules. The valuation premium—62.9x earnings and 39.1x EV/EBITDA—leaves little room for execution missteps or program delays. While management has demonstrated disciplined capital allocation and operational improvement, the stock price assumes continued strong performance.

The central variables to monitor are defense program stability and margin expansion velocity. If Graham can maintain its sole-source positions while diversifying into SMRs and commercial space, the premium valuation will be supported by sustainable growth and mid-teen margins. If defense budgets shift or integration challenges emerge, the concentration risk that created the opportunity could also impact it. For investors, Graham offers a compelling story of industrial transformation, but one that requires monitoring the defense spending environment that underpins the thesis.

Create a free account to continue reading

Get unlimited access to research reports on 5,000+ stocks.

FREE FOREVER — No credit card. No obligation.

Continue with Google Continue with Microsoft
— OR —
Unlimited access to all research
20+ years of financial data on all stocks
Follow stocks for curated alerts
No spam, no payment, no surprises

Already have an account? Log in.